Watchlist Price Alert

Gain Therapeutics Inc. (GANX)

NASDAQ: GANX · Real-Time Price · USD

1.79

-0.01 (-0.56%)

At close: May 29, 2025, 3:59 PM

1.82

1.39%

After-hours: May 29, 2025, 06:13 PM EDT

Gain Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Cash & Equivalents	10.39M	11.79M	7.31M	36.88M	7.49M	303.32K	400.69K
Short-Term Investments	n/a	5M	12.83M	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	1.94M	31.28K	n/a	10.38K	n/a
Other Long-Term Assets	63.8K	51.91K	48.32K	53.39K	63.82K	1.03K	11.21K
Receivables	765.76K	242.58K	103.88K	113.59K	66.56K	44.91K	n/a
Inventory	n/a	n/a	n/a	n/a	1.36M	31.48K	n/a
Other Current Assets	369.89K	242.58K	552.88K	195.45K	n/a	n/a	93.94K
Total Current Assets	11.6M	17.78M	21.09M	37.72M	8.99M	429.52K	494.64K
Property-Plant & Equipment	323.33K	585.18K	804.31K	1.01M	552.71K	219.35K	305.79K
Goodwill & Intangibles	134.27K	193.38K	213.97K	202.61K	n/a	n/a	n/a
Total Long-Term Assets	521.41K	830.46K	3.01M	1.26M	616.53K	230.76K	317K
Total Assets	12.12M	18.61M	24.1M	38.99M	9.6M	660.29K	811.63K
Account Payables	946.26K	1.32M	1.63M	560.48K	961.52K	154.44K	149.33K
Deferred Revenue	252.21K	1.12M	55.18K	266.5K	239.48K	368.8K	n/a
Short-Term Debt	110.18K	118.8K	108.14K	322.96K	22.63K	n/a	n/a
Other Current Liabilities	18.49K	1.38M	364.11K	718.08K	94.71K	3.7K	159.51K
Total Current Liabilities	3.91M	4.95M	4.13M	2.55M	2.11M	879.05K	530.79K
Long-Term Debt	328.33K	449.05K	495.26K	590.47K	715.66K	n/a	1.01M
Other Long-Term Liabilities	443.62K	307.45K	157.58K	329.46K	171.56K	132.25K	23.98K
Total Long-Term Liabilities	872.99K	1.08M	1.09M	1.61M	1.29M	231.09K	1.23M
Total Liabilities	4.78M	6.03M	5.22M	4.17M	3.4M	1.11M	1.76M
Total Debt	653.01K	1.03M	1.27M	1.61M	1.26M	200.95K	1.21M
Common Stock	2.71K	1.62K	1.19K	1.19K	402.00	225.00	225.00
Retained Earnings	-81.19M	-60.78M	-38.52M	-20.93M	-7.03M	-3.46M	-1.26M
Comprehensive Income	-247.55K	247.24K	35.63K	-90.64K	-152.7K	-81.16K	3.08K
Shareholders Equity	7.34M	12.58M	18.88M	34.82M	6.2M	-449.86K	-950.91K
Total Investments	n/a	5M	14.77M	31.28K	n/a	10.38K	n/a